Cantel Medical Corp. (CMD) Reports In-Line Q3 EPS, Miss on Revenues

Cantel Medical Corp. (NYSE: CMD) reported Q3 EPS of $0.51, in-line with the analyst estimate of $0.51. Revenue for the quarter came in at $192.11 million versus the consensus estimate of $194.85 million.

For earnings history and earnings-related data on Cantel Medical Corp. (CMD) click here.

You May Also Be Interested In

• Procter & Gamble (PG) revenue falls short of expectations, raises full-year earnings guidance
• Wipro (WIT) Tops Q1 EPS by 1c
• Acme United (ACU) Misses Q1 EPS by 20c